MétaCan
Menu
Back to cohort

Fixed-dose combination vs. add-on approach as initial treatment in patients with ambulatory systolic hypertension

2005· article· en· W2012818597 on OpenAlexaff
Yves Lacourcière, Luc Poirier, J Lefèbvre

Bibliographic record

VenueAmerican Journal of Hypertension · 2005
Typearticle
Languageen
FieldMedicine
TopicBlood Pressure and Hypertension Studies
Canadian institutionsCentre hospitalier universitaire de Québec
Fundersnot available
KeywordsMedicineHydrochlorothiazideAmbulatory blood pressureAmbulatoryBlood pressureAtenololAmlodipineLosartanMorningDiastoleRegimenInternal medicineDiureticAntihypertensive drugUrologyCardiologyAngiotensin II

Abstract

fetched live from OpenAlex

More than one drug is often needed in treating patients with the systolic form of hypertension. The efficacy of 2 types of antihypertensive combination therapy on 24-hour blood pressure profile was compared in patients who have elevated systolic blood pressure (SBP) both in clinic (>150mmHg) and during daytime ambulatory monitoring (>135mmHg). Eligible patients (n=121; 40F/81M) were randomized to received a once daily morning regimen with either Losartan (L) 50 mg plus hydrochlorothiazide (H) 12.5 mg (Group 1; n=60) or H 12.5 mg (Group 2; n=61). If the target SBP (mean daytime ambulatory ≤ 135 mm Hg) was not achieved after 6 weeks of treatment, drug regimens were titrated up to L 100 mg plus H 25 mg or to H 12,5 mg plus Atenolol 50 mg for an additional 6-week period. Amlodipine 5 mg was then added as a third drug in combination for a further 6 weeks in non responders of each group. Clinic and ambulatory BP were measured after 6, 12 and 18 weeks. Daytime ambulatory systolic/diastolic BP were comparable in Group 1 (152.6/87.0 mmHg) and Group 2 (154.3/89.0 mmHg) at baseline. Average decreases were −9.8/−4.4, −16.0/−8.0 and −22.3/−11.3 mmHg in Group 1 and −2.2/−0.1, −12.3/−8.1 and −20.1/−12.0 mmHg in Group 2, after 6, 12 and 18 weeks, respectively. All reductions were significant (p<0.0001) except for Group 2 at 6 weeks. Although BP reductions at end point (18 weeks) were comparable between groups, the percentage of patients who reached the goal daytime ambulatory SBP was significantly higher (p=0.008) in Group 1 (63.5%) than in Group 2 (37.5%). Furthermore, twice as many patients in Group 1 (30%) acheived the goal daytime SBP with no more than 2 drugs, as compared to Group 2 (14.7%; p=0.03 vs. Group 1). The change from baseline to week 18 in mean daytime ambulatory pulse pressure was also significantly greater (p<0.05) in Group 1 (-11.0 mmHg) than in Group 2 (-8.1 mmHg). Tolerability was better in Group 1 with a 40.0% incidence of possibly to definitively related adverse events, compared to 65.6% in Group 2 (p=0.006 vs. Group 1). In conclusion, initiating an antihypertensive therapy by the combination of L plus H in patients with predominant systolic hypertension allows to reach goal BP faster, in a higher proportion of patients, with fewer adverse events and a lesser need for a third drug than the conventional add-on approach of H plus a beta-blocker.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.251
Teacher spread0.228 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of HypertensionSame topicBlood Pressure and Hypertension StudiesFrench-language works237,207